1-3 of 3
Maneka Puligandla
Close
Sort by
Journal Articles

Low-cost transcriptional diagnostic to accurately categorize lymphomas in low- and middle-income countries

Global Advances
Fabiola Valvert, Oscar Silva, Elizabeth Solórzano-Ortiz, Maneka Puligandla, Marcos Mauricio Siliézar Tala, Timothy Guyon, Samuel L. Dixon, Nelly López, Francisco López, César Camilo Carías Alvarado, Robert Terbrueggen, Kristen E. Stevenson, Yasodha Natkunam, David M. Weinstock, Edward L. Briercheck
Journal: Blood Advances
Blood Adv (2021) 5 (10): 2447–2455.
https://doi.org/10.1182/bloodadvances.2021004347
Published: 2021
Includes: Supplemental data
Journal Articles

Dose-adjusted enoxaparin thromboprophylaxis in hospitalized cancer patients: a randomized, double-blinded multicenter phase 2 trial

Clinical Trials & Observations
Jeffrey I. Zwicker, Joanna Roopkumar, Maneka Puligandla, Benjamin L. Schlechter, Anish V. Sharda, David Peereboom, Robin Joyce, Bruno Bockorny, Donna Neuberg, Kenneth A. Bauer, Alok A. Khorana
Journal: Blood Advances
Blood Adv (2020) 4 (10): 2254–2260.
https://doi.org/10.1182/bloodadvances.2020001804
Published: 2020
Journal Articles

Randomized phase 2 trial of regadenoson for treatment of acute vaso-occlusive crises in sickle cell disease

Clinical Trials & Observations
Joshua J. Field, Elaine Majerus, Victor R. Gordeuk, Michel Gowhari, Carolyn Hoppe, Matthew M. Heeney, Maureen Achebe, Alex George, Hillary Chu, Brian Sheehan, Maneka Puligandla, Donna Neuberg, Gene Lin, Joel Linden, David G. Nathan
Journal: Blood Advances
Blood Adv (2017) 1 (20): 1645–1649.
https://doi.org/10.1182/bloodadvances.2017009613
Published: 2017
Includes: Supplemental data